Skip to main content
FinSpry Logo
FinSpry
MDGL logo
MDGL
(NASDAQ)
Madrigal Pharmaceuticals, Inc.
$546.89-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Madrigal Pharmaceuticals (MDGL) Stock Price & Financial Analysis

Madrigal Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$522.49 - $547.98
52-Week High$615.00
52-Week Low$265.00
Open$531.19
Volume343.94K
Average Volume (3M)343.94K
Market Cap12.27B
Shares Outstanding22.43M
Price to Sales (P/S)12.40
Price to Book (P/B)19.72
EV/EBITDA-45.53
Revenue (TTM)958.40M
Net Income (TTM)-288.28M
Free Cash Flow (TTM)-190.02M
EPS (TTM)$-12.85
Profit Margin-30.08%
Operating Margin-31.31%
Return on Equity (ROE)-47.83%
Debt to Equity0.59
50-Day MA$465.78
200-Day MA$445.60
52-Week Change63.54%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Madrigal Pharmaceuticals

What is the current stock price for MDGL?

As of the latest trading session, MDGL stock trades at $546.89. The 52-week range is $265.00–$615.00, with a day range of $522.49–$547.98.

What is the P/E ratio for MDGL?

The P/E ratio (Price-to-Earnings) for MDGL is shown in the Key Statistics section. This valuation metric helps compare Madrigal Pharmaceuticals, Inc. to industry peers.

Does MDGL pay dividends?

Madrigal Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MDGL?

Based on 3 analysts, the consensus for MDGL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MDGL?

Madrigal Pharmaceuticals's market capitalization is $12.27B, classifying it as a large-cap company. Madrigal Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.